Keyword: Silence Therapeutics
Mallinckrodt is teaming up with Silence Therapeutics to develop an RNAi program aimed at a group of proteins that play a part in promoting inflammation.
Human Longevity CFO/COO departs after scandal; Sangamo loses another top executive; McCann Health fires chief creative for conduct violation and more.
In this week's EuroBiotech Report, U.K. Brexit hopes take shape, BioNTech posts cancer vaccine data, GSK pens AI pact and more.
Silence Therapeutics has asked the U.K. High Court of Justice to rule on an intellectual property dispute with Alnylam and The Medicines Company.